Pick a condition to see which stem-cell types clinics commonly use for it, how they work, and where each sits on evidence and cost. Educational only — not a treatment recommendation.
Cell-free exosomes and iPSC-derived approaches are the fastest-growing area in 2026 (easier manufacturing, off-the-shelf) — but most uses remain investigational.
Multi-lineage differentiating stress-enduring (Muse) cells are a rare endogenous population able to survive harsh conditions, migrate to sites of injury and differentiate across germ layers without forming teratomas.
Chondrocytes are the only resident cell of healthy cartilage. Expanded under GMP conditions they are used to resurface focal cartilage defects and support joint function.
Umbilical-cord (Wharton's jelly) fibroblasts are young, highly proliferative cells rich in growth factors and extracellular-matrix proteins, applied in aesthetic and regenerative protocols.
Fetal stem cells carry broad differentiation potential and low immunogenicity. They form the historical core of several European regenerative programmes and remain a defined research area.
Neurogenic (neural-lineage) cells are directed toward neuronal and glial phenotypes and are studied in neurodegenerative and neurodevelopmental contexts.
Placental amniotic-membrane MSCs are immunomodulatory, anti-inflammatory and paracrine-active mesenchymal cells — the most widely studied cell type in modern regenerative medicine.
Embryonic stem cells are pluripotent and can in principle form any cell type. Their clinical use is tightly regulated and protocol-specific.
Placenta extract delivers a concentrate of peptides, growth factors and nucleotides used in revitalisation and recovery protocols.
Exosomes are nanoscale vesicles that carry the regenerative signalling cargo of stem cells without the cells themselves — a fast-growing, cell-free approach in aesthetics and recovery.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起，仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估